Brief: Acelrx Pharmaceuticals - On Oct 18, Received Written Notice From Nasdaq Notifying Co That It Is Not In Compliance With Minimum Bid Price Requirement
20/10/2023 21:57
Oct 20 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS - ON OCT 18, RECEIVED WRITTEN
NOTICE FROM
NASDAQ NOTIFYING CO THAT IT IS NOT IN COMPLIANCE WITH MINIMUM
BID PRICE REQUIREMENT
* ACELRX PHARMACEUTICALS INC - WILL EVALUATE AVAILABLE
OPTIONS TO
REGAIN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:
Further company coverage: ACRX.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial